Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-01-19

AUTHORS

Pierre Bouju, Jean-Marc Tadié, Nicolas Barbarot, Julien Letheulle, Fabrice Uhel, Pierre Fillatre, Guillaume Grillet, Angélique Goepp, Yves Le Tulzo, Arnaud Gacouin

ABSTRACT

Background Despite few studies, a monitoring of a neuromuscular blockade with a train of four (TOF) is recommended in intensive care unit (ICU). Our objective was to compare the results of ulnar and facial TOF measurements with an overall clinical assessment for neuromuscular blockade in ICU patients treated with recommended doses of atracurium or cisatracurium, including patients with acute respiratory disease syndrome (ARDS).MethodsWe prospectively included in two ICUs 119 patients, 94 with ARDS, who required a neuromuscular blockade for more than 24 h. Three levels of neuromuscular blockade were defined: “over-paralyzed” (TOF = 0), “well-paralyzed” (TOF = 1–2), and “under-paralyzed” (TOF = 3–4). Physicians blinded for TOF counts were asked to classify patients clinically as “over-paralyzed,” “well-paralyzed,” or “under-paralyzed”. Patients were assessed two times daily.ResultsFor the whole population 996 ulnar and facial TOF measurements and clinical assessments were obtained (846 with cisatracurium and 150 with atracurium). Proportions of patients classified as over-paralyzed, well-paralyzed, and under-paralyzed based on TOF measurements and clinical assessments differed significantly (p < 0.0001). The number of observed agreements between clinical assessments and facial TOF measurements was of 19.08% (κ = 0.06) and of 17.37% with ulnar TOF measurements (κ = 0.04), while it was of 62.75% between ulnar and facial TOF measurements (κ = 0.45). Results were similar for cisatracurium and atracurium. Repeated facial TOF measurements performed on the first 4 days of mechanical ventilation in ARDS patients showed that the proportion of patients TOF = 1–2 was around 8% and did not vary significantly with time (p = 0.9), proportion of patients TOF = 3–4 increased from 24 to 40% (p = 0.01), proportion of patients TOF = 0 decreased from 71 to 53% (p = 0.005) while objectives for protective ventilation were achieved. Proportions of facial and ulnar TOF = 0 were significantly higher among patients with ICU-acquired weakness (ICU-AW) versus those who did not develop ICU-AW (51 vs. 40%, p = 0.03, and 76 vs. 62%, p = 0.006, respectively).ConclusionsThe study provides data on clinical and TOF monitoring of neuromuscular blockade, which are widely divergent in ICU patients receiving recommended doses of benzylisoquinoliniums. More... »

PAGES

10

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13613-017-0234-0

DOI

http://dx.doi.org/10.1186/s13613-017-0234-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1008943407

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28102521


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043, Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.462699.6", 
          "name": [
            "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033, Rennes, France", 
            "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043, Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bouju", 
        "givenName": "Pierre", 
        "id": "sg:person.01207334156.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207334156.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inserm-CIC-1414, Universit\u00e9 Rennes I, IFRI 40, 35033, Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.410368.8", 
          "name": [
            "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033, Rennes, France", 
            "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043, Rennes, France", 
            "Inserm-CIC-1414, Universit\u00e9 Rennes I, IFRI 40, 35033, Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tadi\u00e9", 
        "givenName": "Jean-Marc", 
        "id": "sg:person.0765631760.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765631760.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "R\u00e9animation polyvalente, CH Saint-Brieuc, 22000, Saint-Brieuc, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "R\u00e9animation polyvalente, CH Saint-Brieuc, 22000, Saint-Brieuc, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Barbarot", 
        "givenName": "Nicolas", 
        "id": "sg:person.01272000323.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272000323.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043, Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.462699.6", 
          "name": [
            "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033, Rennes, France", 
            "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043, Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Letheulle", 
        "givenName": "Julien", 
        "id": "sg:person.0736551220.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736551220.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inserm-CIC-1414, Universit\u00e9 Rennes I, IFRI 40, 35033, Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.410368.8", 
          "name": [
            "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033, Rennes, France", 
            "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043, Rennes, France", 
            "Inserm-CIC-1414, Universit\u00e9 Rennes I, IFRI 40, 35033, Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Uhel", 
        "givenName": "Fabrice", 
        "id": "sg:person.01033600764.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033600764.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043, Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.462699.6", 
          "name": [
            "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033, Rennes, France", 
            "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043, Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fillatre", 
        "givenName": "Pierre", 
        "id": "sg:person.01273730565.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273730565.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033, Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.411154.4", 
          "name": [
            "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033, Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grillet", 
        "givenName": "Guillaume", 
        "id": "sg:person.01171303723.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171303723.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "R\u00e9animation polyvalente, CH Saint-Brieuc, 22000, Saint-Brieuc, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "R\u00e9animation polyvalente, CH Saint-Brieuc, 22000, Saint-Brieuc, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goepp", 
        "givenName": "Ang\u00e9lique", 
        "id": "sg:person.012564331073.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012564331073.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inserm-CIC-1414, Universit\u00e9 Rennes I, IFRI 40, 35033, Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.410368.8", 
          "name": [
            "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033, Rennes, France", 
            "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043, Rennes, France", 
            "Inserm-CIC-1414, Universit\u00e9 Rennes I, IFRI 40, 35033, Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Le Tulzo", 
        "givenName": "Yves", 
        "id": "sg:person.01272505323.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272505323.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inserm-CIC-1414, Universit\u00e9 Rennes I, IFRI 40, 35033, Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.410368.8", 
          "name": [
            "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033, Rennes, France", 
            "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043, Rennes, France", 
            "Inserm-CIC-1414, Universit\u00e9 Rennes I, IFRI 40, 35033, Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gacouin", 
        "givenName": "Arnaud", 
        "id": "sg:person.0725601723.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725601723.28"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s40140-016-0155-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019235061", 
          "https://doi.org/10.1007/s40140-016-0155-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00134-002-1508-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046818553", 
          "https://doi.org/10.1007/s00134-002-1508-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001340100964", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036337037", 
          "https://doi.org/10.1007/s001340100964"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/2110-5820-4-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031728464", 
          "https://doi.org/10.1186/2110-5820-4-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/cc12557", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008813810", 
          "https://doi.org/10.1186/cc12557"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01709751", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052044737", 
          "https://doi.org/10.1007/bf01709751"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-01-19", 
    "datePublishedReg": "2017-01-19", 
    "description": "Background\nDespite few studies, a monitoring of a neuromuscular blockade with a train of four (TOF) is recommended in intensive care unit (ICU). Our objective was to compare the results of ulnar and facial TOF measurements with an overall clinical assessment for neuromuscular blockade in ICU patients treated with recommended doses of atracurium or cisatracurium, including patients with acute respiratory disease syndrome (ARDS).MethodsWe prospectively included in two ICUs 119 patients, 94 with ARDS, who required a neuromuscular blockade for more than 24\u00a0h. Three levels of neuromuscular blockade were defined: \u201cover-paralyzed\u201d (TOF\u00a0=\u00a00), \u201cwell-paralyzed\u201d (TOF\u00a0=\u00a01\u20132), and \u201cunder-paralyzed\u201d (TOF\u00a0=\u00a03\u20134). Physicians blinded for TOF counts were asked to classify patients clinically as \u201cover-paralyzed,\u201d \u201cwell-paralyzed,\u201d or \u201cunder-paralyzed\u201d. Patients were assessed two times daily.ResultsFor the whole population 996 ulnar and facial TOF measurements and clinical assessments were obtained (846 with cisatracurium and 150 with atracurium). Proportions of patients classified as over-paralyzed, well-paralyzed, and under-paralyzed based on TOF measurements and clinical assessments differed significantly (p\u00a0<\u00a00.0001). The number of observed agreements between clinical assessments and facial TOF measurements was of 19.08% (\u03ba\u00a0=\u00a00.06) and of 17.37% with ulnar TOF measurements (\u03ba\u00a0=\u00a00.04), while it was of 62.75% between ulnar and facial TOF measurements (\u03ba\u00a0=\u00a00.45). Results were similar for cisatracurium and atracurium. Repeated facial TOF measurements performed on the first 4\u00a0days of mechanical ventilation in ARDS patients showed that the proportion of patients TOF\u00a0=\u00a01\u20132 was around 8% and did not vary significantly with time (p\u00a0=\u00a00.9), proportion of patients TOF\u00a0=\u00a03\u20134 increased from 24 to 40% (p\u00a0=\u00a00.01), proportion of patients TOF\u00a0=\u00a00 decreased from 71 to 53% (p\u00a0=\u00a00.005) while objectives for protective ventilation were achieved. Proportions of facial and ulnar TOF\u00a0=\u00a00 were significantly higher among patients with ICU-acquired weakness (ICU-AW) versus those who did not develop ICU-AW (51 vs. 40%, p\u00a0=\u00a00.03, and 76 vs. 62%, p\u00a0=\u00a00.006, respectively).ConclusionsThe study provides data on clinical and TOF monitoring of neuromuscular blockade, which are widely divergent in ICU patients receiving recommended doses of benzylisoquinoliniums.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s13613-017-0234-0", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1045300", 
        "issn": [
          "2110-5820"
        ], 
        "name": "Annals of Intensive Care", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "keywords": [
      "acute respiratory disease syndrome", 
      "intensive care unit", 
      "neuromuscular blockade", 
      "clinical assessment", 
      "ICU patients", 
      "doses of atracurium", 
      "doses of cisatracurium", 
      "proportion of patients", 
      "prospective descriptive study", 
      "overall clinical assessment", 
      "respiratory disease syndrome", 
      "protective ventilation", 
      "ARDS patients", 
      "ICU-AW", 
      "ill patients", 
      "care unit", 
      "mechanical ventilation", 
      "TOF count", 
      "TOF monitoring", 
      "patients", 
      "blockade", 
      "cisatracurium", 
      "atracurium", 
      "disease syndrome", 
      "descriptive study", 
      "doses", 
      "ConclusionsThe study", 
      "ventilation", 
      "observed agreement", 
      "proportion", 
      "assessment", 
      "benzylisoquinoliniums", 
      "syndrome", 
      "MethodsWe", 
      "physicians", 
      "study", 
      "count", 
      "days", 
      "objective", 
      "monitoring", 
      "TOF", 
      "levels", 
      "background", 
      "weakness", 
      "time", 
      "results", 
      "measurements", 
      "data", 
      "number", 
      "units", 
      "train", 
      "agreement", 
      "TOF measurements"
    ], 
    "name": "Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: a prospective descriptive study", 
    "pagination": "10", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1008943407"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13613-017-0234-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28102521"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13613-017-0234-0", 
      "https://app.dimensions.ai/details/publication/pub.1008943407"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-10T10:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_746.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s13613-017-0234-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13613-017-0234-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13613-017-0234-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13613-017-0234-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13613-017-0234-0'


 

This table displays all metadata directly associated to this object as RDF triples.

213 TRIPLES      22 PREDICATES      85 URIs      71 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13613-017-0234-0 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N98fc2a8a6a91465bb2be3c012b925945
4 schema:citation sg:pub.10.1007/bf01709751
5 sg:pub.10.1007/s00134-002-1508-y
6 sg:pub.10.1007/s001340100964
7 sg:pub.10.1007/s40140-016-0155-8
8 sg:pub.10.1186/2110-5820-4-3
9 sg:pub.10.1186/cc12557
10 schema:datePublished 2017-01-19
11 schema:datePublishedReg 2017-01-19
12 schema:description Background Despite few studies, a monitoring of a neuromuscular blockade with a train of four (TOF) is recommended in intensive care unit (ICU). Our objective was to compare the results of ulnar and facial TOF measurements with an overall clinical assessment for neuromuscular blockade in ICU patients treated with recommended doses of atracurium or cisatracurium, including patients with acute respiratory disease syndrome (ARDS).MethodsWe prospectively included in two ICUs 119 patients, 94 with ARDS, who required a neuromuscular blockade for more than 24 h. Three levels of neuromuscular blockade were defined: “over-paralyzed” (TOF = 0), “well-paralyzed” (TOF = 1–2), and “under-paralyzed” (TOF = 3–4). Physicians blinded for TOF counts were asked to classify patients clinically as “over-paralyzed,” “well-paralyzed,” or “under-paralyzed”. Patients were assessed two times daily.ResultsFor the whole population 996 ulnar and facial TOF measurements and clinical assessments were obtained (846 with cisatracurium and 150 with atracurium). Proportions of patients classified as over-paralyzed, well-paralyzed, and under-paralyzed based on TOF measurements and clinical assessments differed significantly (p < 0.0001). The number of observed agreements between clinical assessments and facial TOF measurements was of 19.08% (κ = 0.06) and of 17.37% with ulnar TOF measurements (κ = 0.04), while it was of 62.75% between ulnar and facial TOF measurements (κ = 0.45). Results were similar for cisatracurium and atracurium. Repeated facial TOF measurements performed on the first 4 days of mechanical ventilation in ARDS patients showed that the proportion of patients TOF = 1–2 was around 8% and did not vary significantly with time (p = 0.9), proportion of patients TOF = 3–4 increased from 24 to 40% (p = 0.01), proportion of patients TOF = 0 decreased from 71 to 53% (p = 0.005) while objectives for protective ventilation were achieved. Proportions of facial and ulnar TOF = 0 were significantly higher among patients with ICU-acquired weakness (ICU-AW) versus those who did not develop ICU-AW (51 vs. 40%, p = 0.03, and 76 vs. 62%, p = 0.006, respectively).ConclusionsThe study provides data on clinical and TOF monitoring of neuromuscular blockade, which are widely divergent in ICU patients receiving recommended doses of benzylisoquinoliniums.
13 schema:genre article
14 schema:inLanguage en
15 schema:isAccessibleForFree true
16 schema:isPartOf N07a9bfb8e3e243f2b29e375fbd2a6de2
17 N91f749565ae74d6592cfbd6b1703368e
18 sg:journal.1045300
19 schema:keywords ARDS patients
20 ConclusionsThe study
21 ICU patients
22 ICU-AW
23 MethodsWe
24 TOF
25 TOF count
26 TOF measurements
27 TOF monitoring
28 acute respiratory disease syndrome
29 agreement
30 assessment
31 atracurium
32 background
33 benzylisoquinoliniums
34 blockade
35 care unit
36 cisatracurium
37 clinical assessment
38 count
39 data
40 days
41 descriptive study
42 disease syndrome
43 doses
44 doses of atracurium
45 doses of cisatracurium
46 ill patients
47 intensive care unit
48 levels
49 measurements
50 mechanical ventilation
51 monitoring
52 neuromuscular blockade
53 number
54 objective
55 observed agreement
56 overall clinical assessment
57 patients
58 physicians
59 proportion
60 proportion of patients
61 prospective descriptive study
62 protective ventilation
63 respiratory disease syndrome
64 results
65 study
66 syndrome
67 time
68 train
69 units
70 ventilation
71 weakness
72 schema:name Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: a prospective descriptive study
73 schema:pagination 10
74 schema:productId N4cdf77b881f348829eee3b87b239297d
75 N7a7d9c31ef1f437ba5bab4239b3d122e
76 N93acde519b034454b8145b720c7a74b1
77 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008943407
78 https://doi.org/10.1186/s13613-017-0234-0
79 schema:sdDatePublished 2022-05-10T10:18
80 schema:sdLicense https://scigraph.springernature.com/explorer/license/
81 schema:sdPublisher N1c54de0fa7a344b49e2184845502c7e7
82 schema:url https://doi.org/10.1186/s13613-017-0234-0
83 sgo:license sg:explorer/license/
84 sgo:sdDataset articles
85 rdf:type schema:ScholarlyArticle
86 N07a9bfb8e3e243f2b29e375fbd2a6de2 schema:issueNumber 1
87 rdf:type schema:PublicationIssue
88 N18ef5dc3a5c2401eb902685021014049 rdf:first sg:person.01273730565.40
89 rdf:rest Nc49b42b2ace947569f5e023fe94f14c2
90 N1c54de0fa7a344b49e2184845502c7e7 schema:name Springer Nature - SN SciGraph project
91 rdf:type schema:Organization
92 N3e9b795d60c4401f80bb7b53c788a263 rdf:first sg:person.0725601723.28
93 rdf:rest rdf:nil
94 N4c18254f96b34cefb4722308fec324e3 rdf:first sg:person.01033600764.36
95 rdf:rest N18ef5dc3a5c2401eb902685021014049
96 N4cdf77b881f348829eee3b87b239297d schema:name pubmed_id
97 schema:value 28102521
98 rdf:type schema:PropertyValue
99 N54676056f4084db4aeb5070b5df74929 rdf:first sg:person.01272000323.25
100 rdf:rest N77a9ea3b54704681a41bc2538258c717
101 N7462a63263744f2cb869811c42a03f17 rdf:first sg:person.01272505323.78
102 rdf:rest N3e9b795d60c4401f80bb7b53c788a263
103 N77a9ea3b54704681a41bc2538258c717 rdf:first sg:person.0736551220.58
104 rdf:rest N4c18254f96b34cefb4722308fec324e3
105 N7a7d9c31ef1f437ba5bab4239b3d122e schema:name dimensions_id
106 schema:value pub.1008943407
107 rdf:type schema:PropertyValue
108 N86b90777dbe047e29794e0bd8ce37f2d rdf:first sg:person.0765631760.11
109 rdf:rest N54676056f4084db4aeb5070b5df74929
110 N91f749565ae74d6592cfbd6b1703368e schema:volumeNumber 7
111 rdf:type schema:PublicationVolume
112 N93acde519b034454b8145b720c7a74b1 schema:name doi
113 schema:value 10.1186/s13613-017-0234-0
114 rdf:type schema:PropertyValue
115 N98fc2a8a6a91465bb2be3c012b925945 rdf:first sg:person.01207334156.95
116 rdf:rest N86b90777dbe047e29794e0bd8ce37f2d
117 Nc49b42b2ace947569f5e023fe94f14c2 rdf:first sg:person.01171303723.73
118 rdf:rest Ndd59cf2b5312430184c35e5415b10056
119 Ndd59cf2b5312430184c35e5415b10056 rdf:first sg:person.012564331073.04
120 rdf:rest N7462a63263744f2cb869811c42a03f17
121 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
122 schema:name Medical and Health Sciences
123 rdf:type schema:DefinedTerm
124 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
125 schema:name Clinical Sciences
126 rdf:type schema:DefinedTerm
127 sg:journal.1045300 schema:issn 2110-5820
128 schema:name Annals of Intensive Care
129 schema:publisher Springer Nature
130 rdf:type schema:Periodical
131 sg:person.01033600764.36 schema:affiliation grid-institutes:grid.410368.8
132 schema:familyName Uhel
133 schema:givenName Fabrice
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033600764.36
135 rdf:type schema:Person
136 sg:person.01171303723.73 schema:affiliation grid-institutes:grid.411154.4
137 schema:familyName Grillet
138 schema:givenName Guillaume
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171303723.73
140 rdf:type schema:Person
141 sg:person.01207334156.95 schema:affiliation grid-institutes:grid.462699.6
142 schema:familyName Bouju
143 schema:givenName Pierre
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207334156.95
145 rdf:type schema:Person
146 sg:person.012564331073.04 schema:affiliation grid-institutes:None
147 schema:familyName Goepp
148 schema:givenName Angélique
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012564331073.04
150 rdf:type schema:Person
151 sg:person.01272000323.25 schema:affiliation grid-institutes:None
152 schema:familyName Barbarot
153 schema:givenName Nicolas
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272000323.25
155 rdf:type schema:Person
156 sg:person.01272505323.78 schema:affiliation grid-institutes:grid.410368.8
157 schema:familyName Le Tulzo
158 schema:givenName Yves
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272505323.78
160 rdf:type schema:Person
161 sg:person.01273730565.40 schema:affiliation grid-institutes:grid.462699.6
162 schema:familyName Fillatre
163 schema:givenName Pierre
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273730565.40
165 rdf:type schema:Person
166 sg:person.0725601723.28 schema:affiliation grid-institutes:grid.410368.8
167 schema:familyName Gacouin
168 schema:givenName Arnaud
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725601723.28
170 rdf:type schema:Person
171 sg:person.0736551220.58 schema:affiliation grid-institutes:grid.462699.6
172 schema:familyName Letheulle
173 schema:givenName Julien
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736551220.58
175 rdf:type schema:Person
176 sg:person.0765631760.11 schema:affiliation grid-institutes:grid.410368.8
177 schema:familyName Tadié
178 schema:givenName Jean-Marc
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765631760.11
180 rdf:type schema:Person
181 sg:pub.10.1007/bf01709751 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052044737
182 https://doi.org/10.1007/bf01709751
183 rdf:type schema:CreativeWork
184 sg:pub.10.1007/s00134-002-1508-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1046818553
185 https://doi.org/10.1007/s00134-002-1508-y
186 rdf:type schema:CreativeWork
187 sg:pub.10.1007/s001340100964 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036337037
188 https://doi.org/10.1007/s001340100964
189 rdf:type schema:CreativeWork
190 sg:pub.10.1007/s40140-016-0155-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019235061
191 https://doi.org/10.1007/s40140-016-0155-8
192 rdf:type schema:CreativeWork
193 sg:pub.10.1186/2110-5820-4-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031728464
194 https://doi.org/10.1186/2110-5820-4-3
195 rdf:type schema:CreativeWork
196 sg:pub.10.1186/cc12557 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008813810
197 https://doi.org/10.1186/cc12557
198 rdf:type schema:CreativeWork
199 grid-institutes:None schema:alternateName Réanimation polyvalente, CH Saint-Brieuc, 22000, Saint-Brieuc, France
200 schema:name Réanimation polyvalente, CH Saint-Brieuc, 22000, Saint-Brieuc, France
201 rdf:type schema:Organization
202 grid-institutes:grid.410368.8 schema:alternateName Inserm-CIC-1414, Université Rennes I, IFRI 40, 35033, Rennes, France
203 schema:name Faculté de Médecine, Biosit, Université Rennes 1, 35043, Rennes, France
204 Inserm-CIC-1414, Université Rennes I, IFRI 40, 35033, Rennes, France
205 Service des Maladies Infectieuses et Réanimation Médicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033, Rennes, France
206 rdf:type schema:Organization
207 grid-institutes:grid.411154.4 schema:alternateName Service des Maladies Infectieuses et Réanimation Médicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033, Rennes, France
208 schema:name Service des Maladies Infectieuses et Réanimation Médicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033, Rennes, France
209 rdf:type schema:Organization
210 grid-institutes:grid.462699.6 schema:alternateName Faculté de Médecine, Biosit, Université Rennes 1, 35043, Rennes, France
211 schema:name Faculté de Médecine, Biosit, Université Rennes 1, 35043, Rennes, France
212 Service des Maladies Infectieuses et Réanimation Médicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033, Rennes, France
213 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...